Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft (Q84145395)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 May 2012
edit
Language Label Description Also known as
English
Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft
scientific article published on 17 May 2012

    Statements

    Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit